‘Groundbreaking’ gene-editing therapy receives ethical thumbs up — By: Catholic News Agency

In an interview with “EWTN News Nightly” anchor Tracy Sabol, National Catholics Bioethics Center President Dr. Joseph Meaney discusses the first-ever therapy approved by the FDA using CRISPR, a genome editing technology. / Credit: “EWTN News Nightly” CNA Newsroom, Dec 12, 2023 / 09:00 am (CNA). A new gene-editing therapy called Casgevy, which is designed…

Read More